Results 21 to 30 of about 3,928,328 (244)

Characterization of the conglomerate form of acetyl-dl-leucine by thermal analysis and solubility measurements [PDF]

open access: yes, 2012
Starting from a mixture of enantiomers in solution, crystallization can generate different types of crystals. In order to determine which type of crystal is obtained in the case of acetylleucine, an active pharmaceutical ingredient (API), analytical ...
B. Biscans   +9 more
core   +1 more source

Life cycle analysis within pharmaceutical process optimization and intensification: Case study of active pharmaceutical ingredient production

open access: yes, 2022
S.3521-3533As the demand for new drugs is rising, the pharmaceutical industry faces the quest of shortening development time, and thus, reducing the time to market. Environmental aspects typically still play a minor role within the early phase of process
Löb, Patrick   +8 more
core   +1 more source

Improving Nefiracetam Dissolution and Solubility Behavior Using a Cocrystallization Approach

open access: yesPharmaceutics, 2020
In this work, we are the first to identify thirteen cocrystals of Nefiracetam, a poor water-soluble nootropic compound. Three of which were obtained with the biocompatible cocrystallization agents citric acid, oxalic acid, and zinc chloride. These latter
Xavier Buol   +6 more
doaj   +1 more source

Dissolution from Ethylene Vinyl Acetate Copolymer Long-Acting Implants: Effect of Model Active Ingredient Size and Shape

open access: yesPharmaceutics, 2022
In recent pharmaceutical applications, an active pharmaceutical ingredient (API) can be mixed with a polymer material to yield a composite long-acting drug-delivery device. These devices boast higher patient compliance, localized drug delivery, and lower
Anne M. Gohn   +6 more
doaj   +1 more source

Results for active pharmaceutical ingredient, pH and retention status.

open access: yes, 2021
Results for active pharmaceutical ingredient, pH and retention status.
Joyce M. Ondicho (11467141)   +3 more
core   +1 more source

Interpretation of Guidelines for Occupational Hazard Assessment and Control of Active Pharmaceutical Ingredient in the Pharmaceutical Industry (T/WSJD60—2024)

open access: yes环境与职业医学
The Guidelines for Occupational Hazard Assessment and Control of Active Pharmaceutical Ingredient in the Pharmaceutical Industry (T/WSJD 60—2024) is the first guiding standard in the field of health in China that focuses on occupational health protection
Ying TANG   +9 more
doaj   +1 more source

Deep Eutectic Solvents as Active Pharmaceutical Ingredient Delivery Systems in the Treatment of Metabolic Related Diseases

open access: yesFrontiers in Pharmacology, 2021
Metabolic related diseases such as cancer, diabetes mellitus and atherosclerosis are major challenges for human health and safety worldwide due to their associations with high morbidity and mortality.
Cixin Huang   +12 more
doaj   +1 more source

Lipase enzymes for sustainable synthesis of chiral active pharmaceutical ingredients (API) and key starting materials [PDF]

open access: yes
Biocatalysis is considered as a green and sustainable process for synthesis of chiral organic building blocks and active pharmaceutical ingredients (API).
Sharada Prasanna, Swain, Moumita, Khanra
core   +1 more source

Cost of goods sold analysis and recommendations to reduce costs of co-packaged mifepristone–misoprostol for medical abortion

open access: yesReproductive Health, 2020
Objective Understanding the price components of the mifepristone/misoprostol (combi-pack) for medical abortion to improve access is critical for identifying strategies to reduce product costs for quality-assured formulations and expanding its ...
Lester Chinery   +4 more
doaj   +1 more source

Improving stereoselectivity of phosphotriesterase (PTE) for kinetic resolution of chiral phosphates

open access: yesFrontiers in Bioengineering and Biotechnology
Specific stereoisomer is paramount as it is vital for optimizing drug efficacy and safety. The quest for the isolation of desired stereoisomer of active pharmaceutical ingredients or key intermediates drives innovation in drug synthetic and biocatalytic ...
Nongluck Jaito   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy